Infected Wound
8
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation
Treatment of Chronic Wounds With Cold Plasma -Plasma Care® vs. Placebo
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Compare Wound Sampling Methods Efficacy in Microbiology Culture
Current Surgical Practices and Surgical Site Infection at Ayder Comprehensive Specialized Hospital in Mekelle, Ethiopia
PeRioperative Omega Three and the Effect on ImmuNity
Adjunctive Phototherapy Treatment of Infected Diabetic Ulcers
The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study